IPCA Labs Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

IPCA Labs Quarterly Results    (IPLB)

Here are the latest quarterly results of IPCA Labs. For more details, see the IPCA Labs financial fact sheet and IPCA Labs share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

IPCA Labs Quarterly Results

No. of Mths
Qtr. Ending
3
Mar-18
3
Jun-18
3
Sep-18
3
Dec-18
3
Mar-19
3
Jun-19
3
Sep-19
3
Dec-19
8-Qtr Chart
Click to enlarge
Net Sales Rs m7,8288,5399,9789,4768,33810,11012,12611,391 
Other income Rs m114136138126146194143176 
Turnover Rs m7,9418,67610,1169,6028,48410,30412,26911,567 
Expenses Rs m6,7297,3998,2507,1596,5918,1609,5108,736 
Gross profit Rs m1,0991,1401,7282,3171,7471,9502,6162,654 
Depreciation Rs m432445432426416420451462 
Interest Rs m6549244963454138 
Profit before tax Rs m7177821,4101,9681,4141,6802,2672,331 
Tax Rs m204127213366319359307365 
Profit after tax Rs m5136551,1971,6021,0951,3211,9601,966 
Gross profit margin %14.013.417.324.520.919.321.623.3 
Effective tax rate %28.416.215.118.622.621.413.515.6 
Net profit margin %6.67.712.016.913.113.116.217.3 
Diluted EPS Rs 4.1 5.2 9.5 12.7 8.7 10.5 15.5 15.6  
Diluted EPS (TTM) Rs 18.5 25.3 27.1 31.4 36.0 41.3 47.4 50.3  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Read: IPCA Labs 3QFY20 Result Performance Review

More Pharmaceuticals Company Quarterly Results:   ALEMBIC LTD  WOCKHARDT  PROCTER & GAMBLE HEALTH  AUROBINDO PHARMA  VENUS REMEDIES  

Compare IPCA LABS With:   ALEMBIC LTD  WOCKHARDT  PROCTER & GAMBLE HEALTH  AUROBINDO PHARMA  VENUS REMEDIES  

Compare IPCA LABS With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 202 Points Lower; Oil & Gas and Power Stocks Witness Selling(Closing)

India share markets witnessed selling pressure during closing hours and ended their day on a negative note. At the closing bell, the BSE Sensex stood lower by 202 points.

Views on news

IPCA LABS Announces Quarterly Results (3QFY20); Net Profit Up 22.8% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, IPCA LABS has posted a net profit of Rs 2 bn (up 22.8% YoY). Sales on the other hand came in at Rs 11 bn (up 20.2% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

SUPRAJIT ENGINEERING Plunges by 5%; BSE 500 Index Down 0.7% (Market Updates)

Feb 17, 2020 | Updated on Feb 17, 2020

SUPRAJIT ENGINEERING share price has plunged by 5% and its current market price is Rs 204. The BSE 500 is down by 0.7%. The top gainers in the BSE 500 Index are RELIANCE INFRA (up 9.5%) and SUVEN LIFESCIENCES (up 5.0%). The top losers are SUPRAJIT ENGINEERING (down 5.1%) and IPCA LABS (down 5.9%).

HIMADRI SPECIALITY CHEMICAL LTD Plunges by 5%; BSE 500 Index Down 0.6% (Market Updates)

Feb 17, 2020 | Updated on Feb 17, 2020

HIMADRI SPECIALITY CHEMICAL LTD share price has plunged by 5% and its current market price is Rs 56. The BSE 500 is down by 0.6%. The top gainers in the BSE 500 Index are RELIANCE INFRA (up 5.9%) and SUVEN LIFESCIENCES (up 5.0%). The top losers are HIMADRI SPECIALITY CHEMICAL LTD (down 5.1%) and IPCA LABS (down 5.2%).

IPCA LABS Plunges by 5%; BSE HEALTHCARE Index Down 0.8% (Market Updates)

Feb 17, 2020 | Updated on Feb 17, 2020

IPCA LABS share price has plunged by 5% and its current market price is Rs 1,440. The BSE HEALTHCARE is down by 0.8%. The top gainers in the BSE HEALTHCARE Index are SUVEN LIFESCIENCES (up 5.0%) and THYROCARE TECHNOLOGIES (up 2.8%). The top losers are IPCA LABS (down 5.3%) and ERIS LIFESCIENCES LIMITED (down 7.3%).

IPCA LABS Announces Quarterly Results (2QFY20); Net Profit Up 63.7% (Quarterly Result Update)

Nov 12, 2019 | Updated on Nov 12, 2019

For the quarter ended September 2019, IPCA LABS has posted a net profit of Rs 2 bn (up 63.7% YoY). Sales on the other hand came in at Rs 12 bn (up 21.5% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

More Views on News

Most Popular

Buy this 'Crorepati Stock' and You Could End Up Stinking Rich (Profit Hunter)

Feb 5, 2020

I'm talking about an individual small cap stock that could go up so many times that they make their investors stinking rich in the process. You definitely want to know more...

This Smallcap Stock Could be the Next Titan (Up 1,400% in 10 Years) (Profit Hunter)

Feb 11, 2020

A blueprint to latch on to the next 'Crorepati' stock - and an event I hope you won't miss on any account.

Will Your Trade Go Up or Down Today? (Fast Profits Daily)

Feb 5, 2020

How you can find out which way your trade is likely to move on any given trading day.

Will Algo Traders Take Away All Your Profits? (Fast Profits Daily)

Feb 11, 2020

How to fight back against algo trading systems.

No Change in My Long-Term View on the Rebirth of India Stocks (The 5 Minute Wrapup)

Feb 6, 2020

Why the recent post budget volatility has not affected my bullish view on the Rebirth of India stocks.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get our special report, Secret to Increasing Your Trading Profits Today Now!
We will never sell or rent your email id.
Please read our Terms

IPCA LABS SHARE PRICE


Feb 17, 2020 03:35 PM

TRACK IPCA LABS

  • Track your investment in IPCA LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON IPCA LABS

IPCA LABS - WYETH LTD COMPARISON

COMPARE IPCA LABS WITH

MARKET STATS